vs
NATURES SUNSHINE PRODUCTS INC（NATR）とProto Labs Inc（PRLB）の財務データ比較。上の社名をクリックして会社を切り替えられます
Proto Labs Incの直近四半期売上が大きい（$139.3M vs $123.8M、NATURES SUNSHINE PRODUCTS INCの約1.1倍）。Proto Labs Incの純利益率が高く（5.8% vs 3.3%、差は2.5%）。Proto Labs Incの前年同期比売上増加率が高い（10.4% vs 4.7%）。過去8四半期でNATURES SUNSHINE PRODUCTS INCの売上複合成長率が高い（5.6% vs 5.3%）
Natures Sunshine Products, Inc.（通称NSP）は、ハーブ、ビタミン、ミネラルを含む栄養補助食品やスキンケアなどのパーソナルケア製品の製造を行っています。本社はユタ州リーハイに置き、同州スパニッシュフォークに生産拠点を構えています。
Proto Labsは各種業界向けに迅速な部品製造サービスを提供する企業です。3Dプリント、CNC加工、板金加工、射出成形により、試作開発から量産まで対応可能なオーダーメイド部品を生産します。製品は医療機器、航空宇宙、電子機器、家電、自動車、消費財など多様な分野で活用されており、本社は米国ミネソタ州にあり、米国内各地に生産拠点を擁しています。
NATR vs PRLB — 直接比較
損益計算書 — Q4 FY2025 vs Q1 FY2026
| 指標 | | |
|---|---|---|
| 売上 | $123.8M | $139.3M |
| 純利益 | $4.1M | $8.1M |
| 粗利率 | 72.5% | 45.6% |
| 営業利益率 | 4.3% | 7.1% |
| 純利益率 | 3.3% | 5.8% |
| 売上前年比 | 4.7% | 10.4% |
| 純利益前年比 | 1379.4% | 125.4% |
| EPS（希薄化後） | $0.23 | $0.29 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | — | $139.3M | ||
| Q4 25 | $123.8M | $136.5M | ||
| Q3 25 | $128.3M | $135.4M | ||
| Q2 25 | $114.8M | $135.1M | ||
| Q1 25 | $113.2M | $126.2M | ||
| Q4 24 | $118.2M | $121.8M | ||
| Q3 24 | $114.6M | $125.6M | ||
| Q2 24 | $110.6M | $125.6M |
| Q1 26 | — | $8.1M | ||
| Q4 25 | $4.1M | — | ||
| Q3 25 | $5.3M | $7.2M | ||
| Q2 25 | $5.3M | $4.4M | ||
| Q1 25 | $4.7M | $3.6M | ||
| Q4 24 | $-321.0K | — | ||
| Q3 24 | $4.3M | $7.2M | ||
| Q2 24 | $1.3M | $4.5M |
| Q1 26 | — | 45.6% | ||
| Q4 25 | 72.5% | 44.2% | ||
| Q3 25 | 73.3% | 45.3% | ||
| Q2 25 | 71.7% | 44.3% | ||
| Q1 25 | 72.1% | 44.1% | ||
| Q4 24 | 72.0% | 42.7% | ||
| Q3 24 | 71.3% | 45.6% | ||
| Q2 24 | 71.4% | 45.0% |
| Q1 26 | — | 7.1% | ||
| Q4 25 | 4.3% | 5.0% | ||
| Q3 25 | 7.0% | 6.5% | ||
| Q2 25 | 3.7% | 3.7% | ||
| Q1 25 | 5.4% | 3.6% | ||
| Q4 24 | 3.8% | -1.2% | ||
| Q3 24 | 4.6% | 6.8% | ||
| Q2 24 | 5.1% | 4.8% |
| Q1 26 | — | 5.8% | ||
| Q4 25 | 3.3% | — | ||
| Q3 25 | 4.2% | 5.3% | ||
| Q2 25 | 4.6% | 3.3% | ||
| Q1 25 | 4.2% | 2.9% | ||
| Q4 24 | -0.3% | — | ||
| Q3 24 | 3.8% | 5.7% | ||
| Q2 24 | 1.2% | 3.6% |
| Q1 26 | — | $0.29 | ||
| Q4 25 | $0.23 | $0.25 | ||
| Q3 25 | $0.30 | $0.30 | ||
| Q2 25 | $0.28 | $0.18 | ||
| Q1 25 | $0.25 | $0.15 | ||
| Q4 24 | $-0.02 | $-0.01 | ||
| Q3 24 | $0.23 | $0.29 | ||
| Q2 24 | $0.07 | $0.18 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $93.9M | $124.0M |
| 総負債低いほど良い | — | — |
| 株主資本純資産 | $161.6M | $683.1M |
| 総資産 | $261.1M | $778.6M |
| 負債/資本比率低いほどレバレッジが低い | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | $124.0M | ||
| Q4 25 | $93.9M | $128.1M | ||
| Q3 25 | $95.6M | $119.2M | ||
| Q2 25 | $81.3M | $103.2M | ||
| Q1 25 | $86.5M | $96.8M | ||
| Q4 24 | $84.7M | $103.1M | ||
| Q3 24 | $78.7M | $100.5M | ||
| Q2 24 | $68.7M | $112.9M |
| Q1 26 | — | $683.1M | ||
| Q4 25 | $161.6M | $673.9M | ||
| Q3 25 | $166.7M | $664.7M | ||
| Q2 25 | $163.7M | $664.7M | ||
| Q1 25 | $167.1M | $656.8M | ||
| Q4 24 | $161.0M | $670.2M | ||
| Q3 24 | $162.6M | $680.0M | ||
| Q2 24 | $156.4M | $685.2M |
| Q1 26 | — | $778.6M | ||
| Q4 25 | $261.1M | $763.4M | ||
| Q3 25 | $264.8M | $756.9M | ||
| Q2 25 | $254.9M | $743.3M | ||
| Q1 25 | $252.7M | $737.5M | ||
| Q4 24 | $240.9M | $743.5M | ||
| Q3 24 | $245.3M | $753.8M | ||
| Q2 24 | $235.8M | $758.2M |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $9.9M | $17.5M |
| フリーキャッシュフロー営業CF - 設備投資 | $7.6M | — |
| FCFマージンFCF / 売上 | 6.1% | — |
| 設備投資強度設備投資 / 売上 | 1.9% | — |
| キャッシュ転換率営業CF / 純利益 | 2.41× | 2.16× |
| 直近12ヶ月FCF直近4四半期 | $28.8M | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | — | $17.5M | ||
| Q4 25 | $9.9M | $16.5M | ||
| Q3 25 | $18.5M | $29.1M | ||
| Q2 25 | $4.3M | $10.6M | ||
| Q1 25 | $2.6M | $18.4M | ||
| Q4 24 | $12.2M | $17.3M | ||
| Q3 24 | $9.6M | $24.8M | ||
| Q2 24 | $1.3M | $14.4M |
| Q1 26 | — | — | ||
| Q4 25 | $7.6M | $8.4M | ||
| Q3 25 | $16.8M | $25.0M | ||
| Q2 25 | $3.0M | $9.1M | ||
| Q1 25 | $1.5M | $17.1M | ||
| Q4 24 | $10.0M | $16.5M | ||
| Q3 24 | $7.9M | $23.2M | ||
| Q2 24 | $-2.0M | $10.2M |
| Q1 26 | — | — | ||
| Q4 25 | 6.1% | 6.2% | ||
| Q3 25 | 13.1% | 18.5% | ||
| Q2 25 | 2.6% | 6.7% | ||
| Q1 25 | 1.3% | 13.6% | ||
| Q4 24 | 8.5% | 13.5% | ||
| Q3 24 | 6.9% | 18.5% | ||
| Q2 24 | -1.9% | 8.2% |
| Q1 26 | — | — | ||
| Q4 25 | 1.9% | 5.9% | ||
| Q3 25 | 1.3% | 3.0% | ||
| Q2 25 | 1.2% | 1.1% | ||
| Q1 25 | 1.0% | 1.0% | ||
| Q4 24 | 1.9% | 0.7% | ||
| Q3 24 | 1.5% | 1.2% | ||
| Q2 24 | 3.0% | 3.3% |
| Q1 26 | — | 2.16× | ||
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 4.03× | ||
| Q2 25 | 0.81× | 2.39× | ||
| Q1 25 | 0.55× | 5.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | 3.44× | ||
| Q2 24 | 0.97× | 3.18× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PRLB
| CNC Machining | $63.2M | 45% |
| Injection Molding | $51.1M | 37% |
| 3D Printing | $20.5M | 15% |
| Sheet Metal | $4.4M | 3% |
| Other Revenue | $207.0K | 0% |
